Lucid Diagnostics Inc expected to post a loss of 30  cents a share - Earnings Preview

Lucid Diagnostics

10/05/2022 03:04

* Lucid Diagnostics Inc  LUCD.OQ   LUCD.O  is expected
to report
results on May 11.
    * The New York City-based  company is expected to report
revenue
of $493.25 thousand, according to the mean estimate from 4
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Lucid Diagnostics
Inc is
for a loss of 30 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lucid
Diagnostics
Inc is $12​, above​ its last closing price of $1.95. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.20       -0.20      -0.32     Missed  -58
 Sep. 30 2021  -0.32       -0.32      -0.49     Missed  -54.7
                                                        ​
 ​​                                                     
                                                        ​
 This summary was machine generated May 10 at 02:04 GMT.  All
figures in US dollars  unless otherwise stated